The ECTRIMS conference may be based in Europe but as the conference has grown so has its global impact on multiple sclerosis treatment. With topics ranging from newly approved therapies to those in the pipeline to those not yet ready for testing there is lots to learn in the yearly event.
Overuse of urinary catheters is a common problem in all hospitals. Intervention is possible.
For patients with multiple sclerosis (MS), disturbances in the thermoregulation can result in episodic hypothermia. It's believed that this is caused by hypothalamic lesions from the disease, however, the specifics are not fully understood. M. Toledano and colleagues from the University of Utah set out to uncover more in a poster session that will be presented at the 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2015) in Barcelona, Spain.
Katarina Fink, an associate in the Department of Clinical Neuroscience at the Karolinska Institutet in Sweden, and colleagues analyzed the influence that multiple sclerosis (MS) has on a woman's fertility – an area that has remained unclear. The findings will be described in a poster session at the 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS 2015) in Barcelona, Spain.
Cats and dogs can be vectors for an eye parasite, a multi-center team in the US Southwest reports. The parasite is called Onchocerca lupi. Six cases, believed to be the first in the US, are reported.
Patients who are morbidly obese need a revised dosing protocol when getting vancomycin.
Even when staph bacteria are not drug resistant, clinicians face prescribing drugs that could cause an adverse reaction including kidney injury. A Pittsburgh team looked at the comparative risk of nafcillin vs. oxacillin.
The European Society of Cardiology's annual conference in London highlighted some of the top work being done in the field over the past year.
PCSK9 inhibitors have been the focus of the cardiology community and with the approval of two medications in the past few months these drugs could soon make their way to a large number of patients needing help managing their cholesterol levels using more than just statins.
Congestive heart failure is a serious condition facing people around the world. Early trials of a gene therapy have showed promise to not only help these patients with the condition but also make their hearts healthier.
Just because researchers go into a study with a hypothesis they hope to prove, it does not mean the results will be what they were hoping for.
Several large groups combined data to look at results of a study on heart failure patients to see whether age and gender affected treatment options prescribed by patients.
Treating one patient for an illness can answer some questions for doctors. However, in many cases looking at the larger patient population can answer not only why the patients got sick, but what can be done to keep them healthy in the long run.
In the time since Florence Nightingale first developed the profession of nursing as it is known today a lot has changed for the men and women in the field. Even still the work they do has been a key part of the medical world as training has increased and improved as well.
The glucose-lowering medication lixisenatide was found not neither increase nor decrease cardiovascular (CV) events compared with placebo in patients afflicted with type 2 diabetes and acute coronary syndrome.
There could be a new first-line treatment for hypertension in patients needing diuretic therapy, according to research presented at the European Society of Cardiology (ESC) Congress conference in London, UK.
In heart failure patients with diabetes and/or chronic kidney disease, a new, non-steroidal mineralocorticoid receptor antagonist called finerenone was no more effective than the currently approved MRA eplerenone in reducing the heart failure biomarker N-terminal pro-B-type natriuretic peptide. But it had other benefits.
It was less than two decades ago that researchers uncovered the role of PCSK9 in a person's body. In just the past few months two new medications have been developed that could go a long way in helping win the fight against bad cholesterol.
A considerable amount of progress has been made in treating diabetes this year both for type 1 and type 2 diabetes. The approval of new medications and potential devices in the future have made for a bright outlook for patients.
Patients with C-Diff are being treated with fecal microbiota transplantation but there is still more research being done in the field to learn more about the potential benefits in the field.
Hormone therapy has proven a very effective option for many women during menopause but there has also been some evidence that it can increase the likelihood of bleeding disorders. A recent study looked at the link between the two.
Whether it is due to doctors waiting to make a diagnosis or patients waiting to see a doctor in the first place, diagnosis delay can be a considerable issue for patients with celiac disease. A recent study looked at just how big a problem this can be in the medical community.
Patients coming out of surgery face a variety of risks even when the operation is done. A group is looking into a new device that can help with patients undergoing abdominal surgery to detect ileus after going under the knife.
The internet can be an endless source of information for patients looking to learn more about their conditions and possible treatments and surgical options. Whether those sources provide the help needed is another issue for healthcare professionals to tackle.
Diabetic kidney disease does not have the telltale signs of other conditions which can make it difficult to spot. However, with the right tests patients can get the treatments they need.
One of the newest developments in the treatment of diabetes is the GLP-1 receptor agonist. With different forms intended for different populations it continues a longstanding pattern of bringing new medications into the pool of options for doctors to choose from.
A flying lacrosse ball weighs more than 5 lbs and goes about 60 mph in the girls' version of the sport. Despite objections that there have been no definitive studies showing wearing headgear protects players, the AMA wants sports authorities to require girls teams to wear helmets.
On Tuesday, the American Medical Association's House of Delegates debated the wisdom of forming a so-called Super PAC to help influence elections. However, the idea raised a number of concerns.
The American Medical Association on Monday called the military's policy of excluding transgender service members "out of date."
As the diabetes epidemic continues to grow doctors are being faced with the task of stopping or reversing the trend.
